Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07504770 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Surgical Glove Compression to Prevent Paclitaxel Neuropathy

Study acronym: Surgical Glove
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Mar 26, 2026 to Oct 26, 2026
    • Eligibility criteria shortened, about 80 words
    v3
  2. Primary completion date: Mar 26, 2026 to Oct 26, 2026
    • Eligibility criteria revised
    • Study title shortened, about 2 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the effect of surgical glove compression as a prophylactic method to prevent paclitaxel-induced peripheral neuropathy. Participants will be randomly assigned to two groups: one receiving standard care, and the other receiving prophylactic surgical glove compression. The study will compare the development, severity of neuropathy in the hands and fingers, and its impact on quality of life.
Trial Details
NCT Number NCT07504770
Lead Sponsor Necmettin Erbakan University
Conditions
(from sponsor)		 Paclitaxel-Induced Peripheral Neuropathy, Breast Cancer, Surgical Glove
Related terms Breast Neoplasms
Enrollment 84 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov